Should government regulate medical software?

Abstract

The role of the US Food and Drug Administration in regulating the software of computer-controlled medical devices is addressed. The FDA draft software review guide's focus on regulating software aspects rather than system aspects, the licensing of manufacturers or individuals engaged in the software development and the effects of regulation of medical software development on small medical manufacturers and start-ups are discussed.<>